Quantcast

Latest Telithromycin Stories

2011-01-12 06:00:00

CHAPEL HILL, N.C., Jan. 12, 2011 /PRNewswire/ -- Cempra Pharmaceuticals presented the broad spectrum and potent activity profile of solithromycin (CEM-101), the first fluoroketolide antibiotic, at the 5th Annual PHEMCE stakeholders workshop and Biomedical Advanced Research and Development Authority (BARDA) industry day on January 10 to 12 in Washington D.C. Solithromycin is a clinical-stage fluoroketolide antibiotic with potent and broad-spectrum activity against gram-positive and...

2010-12-01 06:00:00

CHAPEL HILL, N.C., Dec. 1, 2010 /PRNewswire/ -- Cempra Pharmaceuticals and HiQScreen today announced the publication of research revealing the molecular mechanisms that could explain certain unique adverse events associated with the ketolide, telithromycin (Ketek(TM)), which led to its restricted use. The study also showed that Cempra's novel fluoroketolide, solithromycin (CEM-101) is unlikely to generate the adverse events seen with telithromycin. The report was published in the...

2010-10-15 07:00:00

CHAPEL HILL, N.C., Oct. 15 /PRNewswire/ -- Cempra Pharmaceuticals today announced poster presentations on its novel fluoroketolide antibiotic, solithromycin (CEM-101), and the Company's proprietary front-loading oral dosing regimen of sodium fusidate, TAKSTA (CEM-102) at the 48th Annual Meeting of the Infectious Diseases Society of America in Vancouver, British Columbia. All presentations are scheduled for 10 a.m. to 6 p.m. PDT on Friday, October 22. Solithromycin (CEM-101) The...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.